122 related articles for article (PubMed ID: 9177471)
21. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
[TBL] [Abstract][Full Text] [Related]
22. 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma.
Yudoh K; Matsuno H; Kimura T
J Lab Clin Med; 1999 Feb; 133(2):120-8. PubMed ID: 9989763
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D affects proliferation of a murine T helper cell clone.
Lacey DL; Axelrod J; Chappel JC; Kahn AJ; Teitelbaum SL
J Immunol; 1987 Mar; 138(6):1680-6. PubMed ID: 3029220
[TBL] [Abstract][Full Text] [Related]
24. 1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes.
Stoeckler JD; Stoeckler HA; Kouttab N; Maizel AL
J Immunol; 1996 Dec; 157(11):4908-17. PubMed ID: 8943395
[TBL] [Abstract][Full Text] [Related]
25. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
26. Effects of 1,25-dihydroxyvitamin D3 on proliferation and differentiation of Caco-2 cells.
Halline AG; Davidson NO; Skarosi SF; Sitrin MD; Tietze C; Alpers DH; Brasitus TA
Endocrinology; 1994 Apr; 134(4):1710-7. PubMed ID: 8137734
[TBL] [Abstract][Full Text] [Related]
27. 1,25-Dihydroxyvitamin D3 acts directly on human lymphocytes and interferes with the cellular response to interleukin-2.
Koren R; Liberman UA; Maron L; Novogrodsky A; Ravid A
Immunopharmacology; 1989; 18(3):187-94. PubMed ID: 2606649
[TBL] [Abstract][Full Text] [Related]
28. Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.
Jackson JL; Young MR
Clin Exp Metastasis; 2003; 20(4):357-64. PubMed ID: 12856723
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of phosphorylation of mitogen-activated protein kinase by 1alpha,25-dihydroxyvitamin D3 in promyelocytic NB4 leukemia cells: a structure-function study.
Song X; Bishop JE; Okamura WH; Norman AW
Endocrinology; 1998 Feb; 139(2):457-65. PubMed ID: 9449611
[TBL] [Abstract][Full Text] [Related]
30. Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes.
Willheim M; Thien R; Schrattbauer K; Bajna E; Holub M; Gruber R; Baier K; Pietschmann P; Reinisch W; Scheiner O; Peterlik M
J Clin Endocrinol Metab; 1999 Oct; 84(10):3739-44. PubMed ID: 10523023
[TBL] [Abstract][Full Text] [Related]
31. Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells.
Koizumi T; Nakao Y; Ishizuka S; Oshida J; Hara N; Ikekawa N; Fijita T
Arch Biochem Biophys; 1990 Feb; 276(2):310-6. PubMed ID: 2407190
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer.
Chen TC; Holick MF; Lokeshwar BL; Burnstein KL; Schwartz GG
Recent Results Cancer Res; 2003; 164():273-88. PubMed ID: 12899529
[TBL] [Abstract][Full Text] [Related]
33. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
Young MR; Halpin J; Wang J; Wright MA; Matthews J; Pak AS
Cancer Res; 1993 Dec; 53(24):6006-10. PubMed ID: 8261414
[TBL] [Abstract][Full Text] [Related]
34. Stimulatory and inhibitory effects of 1,25-dihydroxyvitamin D3 on thymocyte mitogenesis induced by phorbol ester and calcium ionophore.
Zilberman Y; Ravid A; Liberman UA; Novogrodsky A; Koren R
Biochim Biophys Acta; 1992 Apr; 1134(3):297-302. PubMed ID: 1558852
[TBL] [Abstract][Full Text] [Related]
35. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
Nagasaki T; Hino M; Inaba M; Nishizawa Y; Morii H; Otani S
Arch Biochem Biophys; 1997 Jul; 343(2):181-7. PubMed ID: 9224728
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of epidermal proliferation in mice with 1 alpha, 25-dihydroxyvitamin D3 and receptor-active 20-EPI analogues of 1 alpha, 25-dihydroxyvitamin D3.
Gniadecki R; Serup J
Biochem Pharmacol; 1995 Mar; 49(5):621-4. PubMed ID: 7887976
[TBL] [Abstract][Full Text] [Related]
37. Decreased immunosuppressive actions of 1α, 25-dihydroxyvitamin D
Liu W; Li H; Hao Y; Li Y; Lv M; Xue F; Liu X; Zhang L; Yang R
Mol Immunol; 2016 Oct; 78():89-97. PubMed ID: 27614264
[TBL] [Abstract][Full Text] [Related]
38. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone.
Tsoukas CD; Provvedini DM; Manolagas SC
Science; 1984 Jun; 224(4656):1438-40. PubMed ID: 6427926
[TBL] [Abstract][Full Text] [Related]
39. 17 beta-oestradiol enhances the stimulatory effect of 1,25-dihydroxyvitamin D3 on alkaline phosphatase activity in human osteosarcoma SaOS-2 cells in a differentiation-dependent manner.
Rao LG; Wylie JN; Kung Sutherland MS; Murray TM
J Endocrinol; 1996 Jan; 148(1):181-7. PubMed ID: 8568466
[TBL] [Abstract][Full Text] [Related]
40. The biological activities of 1alpha,25-dihydroxyvitamin D3 and its synthetic analog 1alpha,25-dihydroxy-16-ene-vitamin D3 in normal human osteoblastic cells and human osteosarcoma SaOS-2 cells are modulated by 17-beta estradiol and dependent on stage of differentiation.
Rao LG; Liu LJ; Rawlins MR; McBroom RJ; Murray TM; Reddy GS; Uskokovic MR; Rao DS; Sutherland MK
Biol Pharm Bull; 2001 Mar; 24(3):242-8. PubMed ID: 11256478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
